FDA approves exagamglogene autotemcel to treat beta-thalassemia

After approving Casgevy (exagamglogene autotemcel) in December to treat sickle cell disease, the U.S. Food and Drug Administration announced Tuesday that the therapy has now been approved to treat patients older than 12 years ...


Study reveals function of little-understood synapse in the brain

New research from Oregon Health & Science University for the first time reveals the function of a little-understood junction between cells in the brain that could have important treatment implications for conditions ranging ...

page 1 from 13